PE Tech Report

NEWSLETTER

Like this article?

Sign up to our free newsletter

Shore Capital Partners acquires spine assets from Cook Medical

Shore Capital Partners’ product platform IZI Medical Products has acquired the vertebroplasty family of products from Cook Medical.

The acquired products are commercially marketed under the Duro-Ject Osteo-Site, Osteo-Force and Vertefix brands, consisting of needles, injectors and cements.
 
These products are used in the growing market for treating vertebral compression fractures through a minimally invasive procedure.
 
“Cook has done an excellent job establishing these products as reliable, high-quality solutions for treating vertebral compression fractures and we have enjoyed working with them on this transaction,” says Greg Groenke, chief executive officer, IZI Medical. “We are excited to increase the market penetration of these products through significant investment in a dedicated sales force, international distributor network, select product enhancements, and new product development, such as a unique and broader cement offering. IZI is also excited to be partnering with Dr. Kieran Murphy as part of the acquisition.”
 
Dr Murphy is a highly regarded neuro-interventional radiologist who invented the primary needle and subsequently developed much of the vertebroplasty product line commercialised by Cook. Dr. Murphy will serve as a key opinion leader and play an integral role in product development for IZI.
 
“This is a transformative acquisition for IZI, and is consistent with the strategy we developed when we partnered with Greg Groenke and the management team at IZI a year ago,” says Don Pierce, a partner of Shore Capital Partners and chairman of the board of IZI. “This acquisition is an excellent fit with the broader strategy of building a leading platform serving the interventional radiology and oncology markets. This product family will extend IZI’s international sales reach and increase the depth of its product portfolio.”
 
Additionally, and concurrent with the product family acquisition, Michael Shaffer will be transitioning from Shore Capital Partners to IZI to serve as its chief financial officer, where he will drive the integration of this acquisition and subsequent investments.

Like this article? Sign up to our free newsletter

MOST POPULAR

FURTHER READING

Featured